Avacta Group Plc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avacta Group Plc with three other
companies in this sector in the United Kingdom:
Puretech Health Plc
sales of £1.95 million [US$2.57 million]
of which 99%
was Growth stage operating companies),
Fusion Antibodies PLC
(£1.91 million [US$2.52 million]
of which 100%
was Pharmaceutical), and
Proteome Sciences PLC
(£3.38 million [US$4.45 million]
Avacta Group Plc reported sales of £2.74 million (US$3.60 million)
July of 2017.
increase of 26.3%
versus 2016, when the company's sales were £2.17 million.